Ovine Pasteurellosis Vaccine: Assessment of the Protective Antibody Titer and Recognition of the Prevailing Serotypes

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 36

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_ARCHRAZI-77-3_034

تاریخ نمایه سازی: 6 دی 1402

Abstract:

Sheep husbandry is considered one of the most important activities in the socio-economic development in the Middle East region, especially in Iraq and Islamic Republic of Iran (IRI). Therefore this study was designed to evaluate the level of ovine pasteurellosis vaccine protective antibody titer and identification of the prevailing serotypes in Iraq (Basrah, Baghdad, Tikrit, Mosul, Erbil). The vaccine was made from pasteurella multosida Bio-type A and the serotypes of Mannheimia haemolytica. This investigation was performed from September ۲۰۲۱ to January ۲۰۲۲, in Iraq. Sheep blood sera samples were obtained from control unvaccinated and vaccinated sheep after ۱۴, ۲۱ and ۲۸ days post vaccination. The results showed that out of ۳۱۹ sheep blood sera samples which were evaluated using indirect Haemagglutination (IHA) test to detect Mannheimia haemolytica serotypes, the high prevalence (۱۰۰ %) of M. haemolytica A۲ was found in all the five study regions area, while ۹۶.۵ % was M. haemolytica A۷ and ۸۸.۱ % was M. haemolytica A۱. The level of antibody titer was measured by specific serum antibody titer of pasteurella multosida Bio-type A. The results revealed that out of ۲۶۸ vaccinated blood sera samples the overall antibody titer were ۱۲ (۳.۸ %), ۱۶ (۵%) and ۱۷ (۵.۳ %) for protective antibody titer of ۱:۱۶۰, ۱:۸۰ and ۱:۴۰ respectively and for antibody titer of ۱:۲۰ were ۱۵ (۴.۷%) and for antibody titer of ۱:۱۰ were ۱۷ (۵.۳ %), whereas the antibody titer in the control group was ۴ (۷.۸ %). The result of this study indicated that the vaccine administered has limited protective power against pasteurella multocida Bio-type A which lead to researchers for further study on identification of specific strain of pasteurella multosida and development of multivalent vaccine including the most prevalent pasteurella serotypes.

Authors

M. T Qasim

Department of Anesthesia, College of Health and Medical Technology, Al-Ayen University, Thi-Qar, Iraq

E Mahdi Mohammed Alakkam

Specialist Obstetrician and Gynecologist, Al-Forat General Hospital, Department of Obstetrics and Gynecology, Baghdad, Iraq

M Mahdi Mohammed

Al-Manara College FOR Medical Sciences, Maysan, Iraq

S. K Hachim

Medical Laboratory Techniques Department, Al-Farahidi University, Baghdad, Iraq

H Sabah Jabr

Anesthesia Techniques Department, Al-Mustaqbal University College, Babylon, Iraq

S Emad Izzat

Al-Nisour University College, Baghdad, Iraq

K. A Mohammed

Department of Medical Physics, Hilla University College, Babylon, Iraq

S. A Hamood

Al-Esraa University College, Baghdad, Iraq

M Shnain Ali

Department of Dentistry, Al-Zahrawi University College, Karbala, Iraq

F Najd Obaid

Altoosi University College, Najaf, Iraq

D Mohsin Al-Dhalemi

The Islamic University, Najaf, Iraq

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Alemneh T, Tewodros A. Sheep and goats pasteurellosis: Isolation, identification, ...
  • Nejiban ZS, Al-Amery MA. Clinical and diagnostic study of sheep ...
  • Radostits OM, Gay CC, Blood DC, Hinchcliff KW, McKenzie R. ...
  • Sahay S, Shome R, Sankarasubramanian J, Vishnu US, Prajapati A, ...
  • Wilson BA, Ho M. Pasteurella multocida: from zoonosis to cellular ...
  • Benkirane A, De Alwis M. Haemorrhagic septicaemia, its significance, prevention ...
  • Ahmed WA. Evaluation of Cross Protective Efficacy of Commercial Vaccines ...
  • Akan M, Öncel T, Sareyyüpoğlu B, Hazıroğlu R, Tel OY, ...
  • Tesfaw L, Jenberie S, Sori H, Sisay T, Negussie H. ...
  • Chandrasekaran S, Hizat K, Saad Z, Johara M, Yeap P. ...
  • Cameron CM, Bester FJ. The inefficacy of polivalent Pasteurella multocida ...
  • نمایش کامل مراجع